Global Growth Will Accelerate in 'Pharmerging' Countries, Says IMS Health
Big Pharma is not yet deeply enough invested in faster-growing markets outside the developed economies
SupplyScape, reborn as TraceLink, is back with the
Pedigree-pioneering team resurfaces with cloud-based collaborative platform
Today's global biopharma cold-chain market is $5.1 billion, growing to $6.6 billion by 2011
FDA's DDMAC Takes Another Stab at Enforcing Fair Balance in Drug Advertising
Agency strives to balance risks and benefits in how drugs are presented in direct-to-consumer (DTC) campaigns
What the iPad Means for Pharma
New Apple gadget could help usher in an era of medical applications fully integrated into a healthcare professional’s day-to-day life
US Prescription Sales Grew 5.1% in 2009 to $300.3 billion, Estimates IMS Health
Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%
Pharmaceutical Shippers' Preparations for 100% Cargo Screening Move Forward
Public Thinks Less of Pharmaceutical Industry in 2009
In latest Harris Interactive study, reputation of the pharmaceutical industry drops, but still fares better than some sectors
Mega-Mergers Affect Real Estate Landscape for Pharma
FDA unveils its Serial Numeric Identifier (SNI) guidance for encoding pharma packages
Code would include NDC number; GS1 coding structure gets a nod
Eli Lilly suffers $75-million burglary of branded products stolen from a Connecticut warehouse
Company says affected lots will no longer be distributed
Industry reaction to federal healthcare reform is mixed
Medication adherence could get an EHR boost
Growing digitization of patient data could break the threshold to better adherence to medication therapies
Sampling package optimization wins HDMA award
AmerisourceBergen Packaging and Pfizer partner to develop a cost-effective starter pack for Toviaz tablets
More European serialization projects test barcodes' utiity
EFPIA wraps up its 2009 test; a new pilot in the UK with Reckett-Benckiser
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'
The Medical Affairs function can play a vital role in today’s product launch process
Smartphone Adoption Has Reached 30% Among Office-Based Physicians, Says SDI Health
Over half of all physicians are participating in social-media sites or online professional networks
Improving Outcomes Research Protocols
Brand Protection Technology Takes a Patient-Communication Turn
How the many anticounterfeiting measures on the market today could turn into a means of connecting with patients
OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?
Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers
Bill Gates: 'Vaccines Are A Miracle'
Coming Together
More and more parts of the healthcare industry are connecting
Agenda Set for Spring HPCLC Meeting
Preparing for the effects of economic recovery on a changed logistics landscape is the theme
IMS Health pursues aggregate-spend reporting with software and service suite
Company partners with R-Squared to provide collect and qualify promotional spending data
PDR Network adds staff, pursues REMS business
‘Dear Doctor’ notification network evolves into a leading provider of REMS program information
Model N extends revenue management process with contract-authoring tools
IT developer promotes concept of 'revenue management life cycle'
Revenue Leakage in Biopharma Distribution Channels Is $11 Billion Annually, Says IDC Health Insights
Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?
Safety Issues Dominate Pain Market
While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD
Unpacking Risk Sharing and Alternative Pricing Schemes
Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them
Healthcare Provider Pushes Back on FDA's REMS Policies
Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution
